Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Toxicology Letters

• Publication date

  2016-09-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.toxlet.2016.07.004PMID 27397758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Development

  2021influential reference
• Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro

  2016cited by this paper
• Catalytic bioscavengers in nerve agent poisoning: A promising approach?

  2016cited by this paper
• European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support.

  2015cited by this paper
• Catalytic Bioscavengers: The New Generation of Bioscavenger-Based Medical Countermeasures

  2015cited by this paper
• Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro

  2014cited by this paper
• Use of OpdA, an organophosphorus (OP) hydrolase, prevents lethality in an African green monkey model of acute OP poisoning.

  2014cited by this paper
• What can we learn on medical preparedness from the use of chemical agents against civilians in Syria?

  2014cited by this paper
• Vascular Access in Resuscitation: Is There a Role for the Intraosseous Route?

  2014cited by this paper
• Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes

  2014cited by this paper
• Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.

  2014cited by this paper
• Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo.

  2014cited by this paper
• Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.

  2013cited by this paper
• Drug development for the management of organophosphorus poisoning

  2013cited by this paper
• Syrian gas attack reinforces need for better anti-sarin drugs

  2013cited by this paper
• The value of novel oximes for treatment of poisoning by organophosphorus compounds.

  2013cited by this paper
• Engineering V-type nerve agents detoxifying enzymes using computationally focused libraries.

  2013cited by this paper
• Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.

  2013cited by this paper
• Limitations and challenges in treatment of acute chemical warfare agent poisoning.

  2013cited by this paper
• Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.

  2012cited by this paper
• Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification.

  2012cited by this paper
• Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.

  2011cited by this paper
• Simultaneous quantification of VX and its toxic metabolite in blood and plasma samples and its application for in vivo and in vitro toxicological studies.

  2011cited by this paper
• Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.

  2011cited by this paper
• Systemic fibrinolysis through intraosseous vascular access in ST-segment elevation myocardial infarction.

  2011cited by this paper
• Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.

  2011cited by this paper
• Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2010cited by this paper
• Kinetics and efficacy of an organophosphorus hydrolase in a rodent model of methyl-parathion poisoning.

  2010cited by this paper
• CHAPTER 70 – Catalytic Bioscavengers: The Next Generation of Bioscavenger-Based Medical Countermeasures

  2009cited by this paper
• Chromatographic resolution, characterisation and quantification of VX enantiomers in hemolysed swine blood samples.

  2008cited by this paper
• Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin

  2008cited by this paper
• Degradation of nerve agents by an organophosphate-degrading agent (OpdA).

  2008cited by this paper
• Toxicology of Organophosphate Nerve Agents

  2007cited by this paper
• Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.

  2007cited by this paper
• Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.

  2006cited by this paper
• A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig.

  2006cited by this paper
• In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.

  2005cited by this paper
• Improved determination of acetylcholinesterase activity in human whole blood.

  1999cited by this paper
• Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.

  1998cited by this paper
• Chemical warfare agents: toxicology and treatment

  1997cited by this paper
• Resuscitation with intraosseous lines in neonatal units

  1993cited by this paper
• Enzyme inhibitors as substrates : interactions of esterases with esters of organophosphorus and carbamic acids

  1972influential reference
• Toxicology Letters

  year unknowncited by this paper

• Role of paraoxonase 1 in organophosphate G-series nerve agent poisoning and future therapeutic strategies

  2024cites this paper
• Bioremediation and Bioscavenging for elimination of Organophosphorus threats: An approach using enzymatic advancements.

  2024cites this paper
• Engineering of a phosphotriesterase with improved stability and enhanced activity for detoxification of the pesticide metabolite malaoxon.

  2023cites this paper
• Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro

  2021cites this paper
• Post-VX exposure treatment of rats with engineered phosphotriesterases

  2021cites this paper
• Management and Modulation of Cholinesterase

  2021cites this paper
• Inhibition of an organophosphate-detoxifying bacterial phosphotriesterase by albumin and plasma thiol components.

  2021cites this paper
• Poisoning by organophosphorus nerve agents and pesticides: An overview of the principle strategies and current progress of mass spectrometry-based procedures for verification

  2021cites this paper
• Overview of a bioremediation tool: organophosphorus hydrolase and its significant application in the food, environmental, and therapy fields

  2021cites this paper
• Toxicokinetic aspects of nerve agents and vesicants

  2020cites this paper
• Recent Trend in Bioscavengers for Inactivation of Toxic Organophosphorus Compounds

  2020cites this paper
• Screening of chiral shift reagents suitable to generically separate the enantiomers of V-agents by 31P-NMR spectroscopy.

  2019cites this paper
• COPD and asthma therapeutics for supportive treatment in organophosphate poisoning

  2019cites this paper
• Aerosolized recombinant human butyrylcholinesterase delivered by a nebulizer provides long term protection against inhaled paraoxon in macaques.

  2019cites this paper
• Microbial Phosphotriesterase: Structure, Function, and Biotechnological Applications

  2019influential citation
• Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents

  2018cites this paper
• Effect of cholinergic crisis on the potency of different emergency anaesthesia protocols in soman-poisoned rats

  2018cites this paper
• Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis.

  2018cites this paper
• Automated Design of Efficient and Functionally Diverse Enzyme Repertoires.

  2018cites this paper
• Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases.

  2018cites this paper
• Catalytic bioscavengers as countermeasures against organophosphate nerve agents.

  2018cites this paper
• Overcoming an optimization plateau in the directed evolution of highly efficient nerve agent bioscavengers

  2017cites this paper
• Precision cut lung slices as test system for candidate therapeutics in organophosphate poisoning.

  2017cites this paper
• Cholinesterase reactivators and bioscavengers for pre‐ and post‐exposure treatments of organophosphorus poisoning

  2017cites this paper